ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program.

SO has guided earnings per share of $4.20-$4.30 for 2025.

Ford's Q1 2025 results exceeded analysts' expectations, but shares fell 2.5% due to management's cautious outlook and trade war impacts. Revenue declined 5% year-over-year, driven by drops in Ford Blue and Ford Pro segments, despite a strong performance from Model e and Ford Credit. Management withdrew 2025 guidance due to uncertainty, citing a $1.5 billion net tariff impact, making short-term investment risky but long-term prospects potentially attractive.

Breast surgeons expressed strong interest in participating in IceCure's planned post-market study for ProSense® in the treatment of early-stage breast cancer ICE3 study named as one of the "Best Papers of 2024" Cryoablation was mentioned favorably during the ASBrS Presidential Address CAESAREA, Israel , May 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it participated in the American Society of Breast Surgeons (ASBrS) 2025 Annual Meeting on April 30 – May 4, 2025 in …

NEW YORK , May 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.

AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform

SAN ANTONIO, Texas--(BUSINESS WIRE)--XPEL, Inc. (Nasdaq: XPEL) (the "Company"), a global provider of protective films and coatings, announced consolidated results1 for the first quarter of 2025. First Quarter 2025 Overview: Revenue increased 15.2% to $103.8 million in the first quarter of 2025. Gross margin of 42.3% in the first quarter of 2025. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased 23.2% to $14.4 million, or 13.9% of revenue, compared to $11.7 milli.

Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m.

Arabic, Italian, and Spanish-language websites unlock commercial access to regions representing over 1.4 billion people Multilingual rollout aligns with product readiness and accelerates international sales pipeline development NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of three new localized websites in Arabic, Italian, and Spanish. This rollout supports the Company's global growth plans and international sales expansion by opening digital and commercial access to some of the world's fastest-growing, high-demand regions for workplace safety and compliance …

DENVER--(BUSINESS WIRE)--Mediacom and CSG extend their nearly 30-year relationship by five years to strengthen customer loyalty and innovation.

NEEDHAM, Mass.--(BUSINESS WIRE)--SharkNinja, Inc. (NYSE: SN), a global product design and technology company, announced it has appointed Kleona Mack as Chief Marketing Officer of Shark Beauty™. Mack, a seasoned marketing executive with more than 15 years of experience in the beauty and fashion industry, most recently served as CMO at Glossier and previously held several leadership roles at L'Oréal. Mack will lead all marketing for Shark's innovative hair care and skincare tools portfolio, repor.

MCLEAN, VA / ACCESS Newswire / May 6, 2025 / Gladstone Commercial Corporation (Nasdaq:GOOD) announces the following event: What: Gladstone Commercial Corporation's First Quarter Ended March 31, 2025 Earnings Call & Webcast When: Thursday, May 8, 2025 @ 8:30 a.m. ET Website: https://event.choruscall.com/mediaframe/webcast.html?webcastid=DCRRMTRB How: By webcast -- Log on to the web at the address above By phone -- Please call (877) 407-9045 Contact: Gladstone Commercial Corporation, (703) 287-5893 A conference call replay will be available after the call and will be accessible through May 15, 2025.

FORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched Lurasidone, a new generic prescription drug in the therapeutic class of antipsychotics. Lurasidone is a generic version of Latuda®.

WHITE PLAINS, NY / ACCESS Newswire / May 6, 2025 / Loar Holdings Inc. (NYSE:LOAR), will report Q1 2025 earnings before the market opens on Tuesday, May 13, 2025. A conference call will follow at 10:30a.m.

FAIRBANKS, AK , May 6, 2025 /PRNewswire/ - Contango ORE, Inc. ("Contango" or the "Company") (NYSE American: CTGO) is pleased to announce that it has completed the Technical Report Summary ("TRS") on the Johnson Tract Project (the "Project" or "Johnson Tract"), located in Alaska, U.S.A. The TRS summarizes the results of an Initial Assessment ("IA") of the potential viability for a seven-year life of mine ("LOM"), underground mining operation, utilizing the same direct ship ore ("DSO") approach as the highly successful Manh Choh mine.

LEWISVILLE, Ark., May 06, 2025 (GLOBE NEWSWIRE) -- Smackover Lithium, a Joint Venture (“JV”) between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE:A:SLI) and Equinor, announced that SWA Lithium LLC has submitted an application to the Arkansas Oil and Gas Commission (“AOGC”) to establish a fair and equitable lithium royalty for the Reynolds Unit for Phase I of its South West Arkansas (“SWA”) Project in Lafayette and Columbia Counties, Arkansas. The hearing is scheduled for Wednesday, May 28th, 2025, at 9:00 am CDT and is to be held at the Donald W. Reynolds Community Center Grand Hall at …

ROCK HILL, S.C., May 06, 2025 (GLOBE NEWSWIRE) -- 3D Systems' (NYSE: DDD) Digital Dentistry Solutions are helping dental laboratories and clinics efficiently deliver patient-specific devices to straighten, protect, repair, and replace teeth with high precision. 3D printing combined with advanced dental materials can now provide individually customized patient solutions faster, better and at a lower cost than conventional technologies. The Company has cemented its leadership in Digital Dentistry by providing the most extensive portfolio of integrated solutions. At the core of 3D Systems' strategy is a portfolio of NextDent® materials that are engineered to address the most comprehensive range …

Two posters presented at Digestive Disease Week (DDW) 2025 Preclinical results indicate that PALI-2108 effectively modulates inflammatory pathways in the colon, promoting a favorable immune response Company advancing Phase 1a/b study of PALI-2108 and has demonstrated a favorable safety profile in single-ascending-dose cohorts Carlsbad, CA, May 06, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced the presentation of positive preclinical data from PALI-2108, an orally administered, colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug …

FORT MYERS, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company's President and Chief Executive Officer, will host one-on-one meetings with investors at the BMO Global Farm to Market Conference, taking place May 14-15, 2025 in New York City, NY.

JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will presentation in the following investor conferences in May 2025.